Umezu T, Takanashi M, Fujita K, Ishikawa A, Harada Y, Matsumoto Y
Mol Ther Nucleic Acids. 2025; 36(1):102438.
PMID: 39877003
PMC: 11773475.
DOI: 10.1016/j.omtn.2024.102438.
Khan M, Boufaied N, Yeganeh M, Kandhi R, Petkiewicz S, Sharma A
Cancers (Basel). 2023; 15(3).
PMID: 36765862
PMC: 9913612.
DOI: 10.3390/cancers15030905.
Liu S, Huang F, Ru G, Wang Y, Zhang B, Chen X
Front Oncol. 2022; 12:902820.
PMID: 35847898
PMC: 9279915.
DOI: 10.3389/fonc.2022.902820.
Kemegne Sipping M, Mediesse F, Kenmogne L, Kanemoto J, Njamen D, Boudjeko T
Evid Based Complement Alternat Med. 2022; 2022:8198859.
PMID: 35463072
PMC: 9019406.
DOI: 10.1155/2022/8198859.
Holczbauer A, Wangensteen K, Shin S
JHEP Rep. 2022; 4(4):100416.
PMID: 35243280
PMC: 8873941.
DOI: 10.1016/j.jhepr.2021.100416.
The DEN and CCl -Induced Mouse Model of Fibrosis and Inflammation-Associated Hepatocellular Carcinoma.
Uehara T, Pogribny I, Rusyn I
Curr Protoc. 2021; 1(8):e211.
PMID: 34370903
PMC: 8744072.
DOI: 10.1002/cpz1.211.
Characterization of the inflammatory microenvironment and hepatic macrophage subsets in experimental hepatocellular carcinoma models.
Degroote H, Lefere S, Vandierendonck A, Vanderborght B, Meese T, Van Nieuwerburgh F
Oncotarget. 2021; 12(6):562-577.
PMID: 33796224
PMC: 7984829.
DOI: 10.18632/oncotarget.27906.
Study on the hepatocellular carcinoma model with metastasis.
Lin Y, Li Y
Genes Dis. 2020; 7(3):336-350.
PMID: 32884988
PMC: 7452459.
DOI: 10.1016/j.gendis.2019.12.008.
Genetically Engineered Mouse Models of Liver Tumorigenesis Reveal a Wide Histological Spectrum of Neoplastic and Non-Neoplastic Liver Lesions.
Steiger K, Gross N, Widholz S, Rad R, Weichert W, Mogler C
Cancers (Basel). 2020; 12(8).
PMID: 32823526
PMC: 7465606.
DOI: 10.3390/cancers12082265.
Prognostic significance of SOCS1 and SOCS3 tumor suppressors and oncogenic signaling pathway genes in hepatocellular carcinoma.
Khan M, Ghosh A, Variya B, Santharam M, Ihsan A, Ramanathan S
BMC Cancer. 2020; 20(1):774.
PMID: 32807134
PMC: 7433106.
DOI: 10.1186/s12885-020-07285-3.
Animal Modeling of Pediatric Liver Cancer.
Whitlock R, Yang T, Vasudevan S, Woodfield S
Cancers (Basel). 2020; 12(2).
PMID: 31979130
PMC: 7072332.
DOI: 10.3390/cancers12020273.
Non-invasive Bioluminescence Monitoring of Hepatocellular Carcinoma Therapy in an HCR Mouse Model.
Zhao Z, Dai J, Yu Y, Zhang Q, Liu S, Huang G
Front Oncol. 2019; 9:864.
PMID: 31572672
PMC: 6749040.
DOI: 10.3389/fonc.2019.00864.
Intratumoral IL-12 Gene Therapy Inhibits Tumor Growth In A HCC-Hu-PBL-NOD/SCID Murine Model.
Zhou Z, Peng F, Li J, Ye Y
Onco Targets Ther. 2019; 12:7773-7784.
PMID: 31571927
PMC: 6760038.
DOI: 10.2147/OTT.S222097.
Characterization of high- and low-risk hepatocellular adenomas by magnetic resonance imaging in an animal model of glycogen storage disease type 1A.
Resaz R, Rosa F, Grillo F, Basso L, Segalerba D, Puglisi A
Dis Model Mech. 2019; 12(4).
PMID: 30898969
PMC: 6505483.
DOI: 10.1242/dmm.038026.
Diethylnitrosamine Increases Proliferation in Early Stages of Hepatic Carcinogenesis in Insulin-Treated Type 1 Diabetic Mice.
Arboatti A, Lambertucci F, Sedlmeier M, Pisani G, Monti J, Alvarez M
Biomed Res Int. 2018; 2018:9472939.
PMID: 29850590
PMC: 5937583.
DOI: 10.1155/2018/9472939.
Role of insulin receptor substrates in the progression of hepatocellular carcinoma.
Sakurai Y, Kubota N, Takamoto I, Obata A, Iwamoto M, Hayashi T
Sci Rep. 2017; 7(1):5387.
PMID: 28710407
PMC: 5511151.
DOI: 10.1038/s41598-017-03299-3.
Dietary restriction protects against diethylnitrosamine-induced hepatocellular tumorigenesis by restoring the disturbed gene expression profile.
Duan T, Sun W, Zhang M, Ge J, He Y, Zhang J
Sci Rep. 2017; 7:43745.
PMID: 28262799
PMC: 5338348.
DOI: 10.1038/srep43745.
Environmental exposures as a risk factor for fibrolamellar carcinoma.
Graham R, Craig J, Jin L, Oliveira A, Bergquist J, Truty M
Mod Pathol. 2017; 30(6):892-896.
PMID: 28256571
DOI: 10.1038/modpathol.2017.7.
Systematic revelation of the protective effect and mechanism of Cordycep sinensis on diethylnitrosamine-induced rat hepatocellular carcinoma with proteomics.
Wang P, Hung Y, Li W, Yeh C, Pan T
Oncotarget. 2016; 7(37):60270-60289.
PMID: 27531890
PMC: 5312383.
DOI: 10.18632/oncotarget.11201.
Emodin-Loaded PLGA-TPGS Nanoparticles Combined with Heparin Sodium-Loaded PLGA-TPGS Nanoparticles to Enhance Chemotherapeutic Efficacy Against Liver Cancer.
Liu H, Xu H, Zhang C, Gao M, Gao X, Ma C
Pharm Res. 2016; 33(11):2828-43.
PMID: 27511028
DOI: 10.1007/s11095-016-2010-5.